Additionally, a time point study of iNOS/COX-2 and MAPK signaling in this study could be the magnificent cues for the further in vivo experiment including both acute (such as ischemia, traumatic brain injury) and chronic (such as AD, PD) inflammatory conditions. This evidence concerns the gene PTGS2 and Alzheimer disease.